Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Submitted by
admin
on January 3, 2014 - 12:50pm
Source:
Drug Discovery and Development
News Tags:
UCB
Amgen
bone density
romosozumab
Headline:
Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Do Not Allow Advertisers to Use My Personal information
